SCHEMBL11486608

SCHEMBL11486608

OCCCC1=NCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10516602 0.86
SCHEMBL5598939 0.79
SCHEMBL3659904 0.76 MEN1 (0.38)
SCHEMBL9376005 0.75
SCHEMBL16160870 0.72
SCHEMBL192000 0.71
SCHEMBL15919221 0.71
SCHEMBL8412913 0.71 NOS3 (0.39)
SCHEMBL12438888 0.69 NOS3 (0.41)
SCHEMBL19622238 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240165089-A1 METHOD FOR TREATING MYOPIA WITH VINPOCETINE Eye Hospital, Wenzhou Medical University (CN) 2024-05-23 US disclosed
WO-2019079607-A1 METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS Epizyme, Inc. (US) 2019-04-25 WO disclosed
EP-0011768-A1 Hydroxypropyl triazoles, process for their preparation and medicaments containing these compounds BAYER AG (DE) 1980-06-11 EP disclosed